ZEOX 8-K SEC Filing Analysis

Latest settled — T+5d

ZEOX ▲ +2.16% at T+5d

NEUTRAL call ✓ call won +2.16% · α vs SPY +1.69% · entry $1.85 → $1.89

Next anchor: T+20d in 12d

Currently $1.70 · -8.11% from $1.85 entry

Entry anchored
May 27, 2026
via day open

T+1d

-2.70%

call -2.70% · α -3.25%

$1.80

settled 16d ago

T+5d

+2.16%

call +2.16% · α +1.69%

$1.89

settled 10d ago

T+20d

—

call — · α —

—

in 12d

T+60d

—

call — · α —

—

in 2mo

Price Chart

Loading chart...

Executive Summary

ZEO ScientifiX announced the formal launch of its Physician-Led Patient Masterclass program, a patient education initiative for regenerative medicine. The program is based on a grassroots model that emerged in Vero Beach, Florida, and follows the company having trained more than 600 physicians in the past year. No financial terms, revenue guidance, or material financial impact were disclosed.

Actionable Insight

This is a routine business development announcement with no immediate financial data. Monitor future 10-Q or 10-K filings for any revenue contribution or cost impact from this program. No trading action warranted based on this filing alone.

Key Facts

Program formalizes a patient education model that originated organically in Vero Beach, Florida
Company has trained more than 600 physicians across the Southeast in the past year
Program targets three indications permitted under Florida law: pain management, wound care, and orthopedics
No financial terms, costs, revenue projections, or material financial data disclosed in the filing
Press release dated May 27, 2026

Financial Impact

No financial terms or expected revenue impact disclosed

Risk Factors

Patient education program may not drive meaningful revenue growth
Regulatory environment for regenerative medicine in Florida could change
Forward-looking statements about demand and scaling carry no guarantees

Market Snapshot

Exchange

OTC

Sector

Biological Products, (No Diagnostic Substances)

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

Document	Accession Number
8-K Filing (Primary)	0001829126-26-005695
Document: zeoscientifix_ex99-1.htm	0001829126-26-005695
Document: 0001829126-26-005695-index-headers.html	0001829126-26-005695
Document: 0001829126-26-005695-index.html	0001829126-26-005695
Document: 0001829126-26-005695.txt	0001829126-26-005695

6 reports for ZEOX

T+1T+5T+20T+60

Track record builds as more directional reports settle.

Filters

Reports for ZEOX — sortable, filterable
	Type				Now
Jun 9, 2026 4d ago	8-K NEUTRAL ★ 2/10	$1.75 awaiting T+5	awaiting T+5	—	$1.70 (−2.86%)
May 27, 2026 17d ago	8-K NEUTRAL ★ 2/10	$1.85 $1.89	▲ +2.16%	▲ +1.69%	$1.70 (−8.11%)
May 12, 2026 4w ago	8-K NEUTRAL ★ 4/10	$2.15 $2.11	▼ −1.86%	▼ −1.94%	$1.70 (−20.93%)
Apr 21, 2026 7w ago	8-K NEUTRAL ★ 3/10	$1.93 $1.83	▼ −5.44%	▼ −6.52%	$1.70 (−11.92%)
Apr 9, 2026 9w ago	8-K BULLISH ★ 6/10	$1.85 $1.85	▼ −0.22%	▼ −3.40%	$1.70 (−8.26%)
Apr 7, 2026 9w ago	8-K BULLISH ★ 7/10	$2.08 $1.76	▼ −15.43%	▼ −20.76%	$1.70 (−18.27%)

US Market Status

Market Closed — Opens Mon (48h 33m)

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access